Project Grant R01AG071995

Award Date 7/1/24
Completion Date 5/31/29
Dollars Obligated $745K
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
California, EE. UU.
Similar Awards
The National Eye Institute (NEI) awarded a $862,580 Project Grant under the Vision Research federal grant program (CFDA 93.867) to The Regents of the University of Colorado for the project "The Aging Eyes Study: Mitochondrial Dysfunction as a Driver of Age-Related Vision Loss". The study aims to investigate the role of mitochondrial function and genetics in the development of age-related eye diseases, with the goal of identifying potential clinical indicators and interventions to...
The National Eye Institute (NEI) awarded a $679,159 Project Grant (CFDA 93.867 - Vision Research) to The Schepens Eye Research Institute, Inc. to investigate the combined effects of aging and elevated intraocular pressure (IOP) on the development of glaucoma and the retinal ganglion cell (RGC) transcriptome. The research aims to: 1) Demonstrate that elevated IOP-induced glaucoma is more severe in aging mice and that transient AAV2-OSK (Oct4, Sox2, Klf4) mediated epigenetic reprogramming can...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), is supporting research to investigate the effects of sleep and intrinsically photosensitive retinal ganglion cells (ipRGCs) on computations in the early visual system. The $360,100 award to The Leland Stanford Junior University aims to: 1) Isolate and measure melanopsin-specific responses in the retina and visual cortex under natural scenes; 2) Record visual cortex responses under...
This Project Grant award from the National Eye Institute (NEI), part of the NIH Vision Research program (CFDA 93.867), will support research to characterize the enzyme adenosylhomocysteinase (AHCY) as a redox-regulated enzyme in the Drosophila eye under oxidative stress. The $193,336 award, spanning September 2024 to July 2026, aims to elucidate how oxidative modifications to AHCY impact its enzymatic activity and regulation of one-carbon metabolism, potentially leading to changes in gene...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to Georgetown University totals $247,033 and supports research to determine the role of sex in age-related visual decline. The primary objectives are to investigate changes to the retinal pigment epithelium (RPE), retina, and visual cortex in a mouse model, focusing on the effects of sex chromosomes, gonadal hormones, and their interactions on visual system aging. The work will be conducted in...
This Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) supports research at Thomas Jefferson University's Sidney Kimmel Medical College to investigate the roles of glucose transport and metabolism in maintaining retinal health and function. The $595,302 award, spanning April 2025 to March 2030, will fund three specific aims: 1) Determining whether the retinal pigment epithelium (RPE) requires glucose for its own biosynthetic and phagocytic activities, rather...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), is funding research to decipher the regulatory mechanisms that control the development of different photoreceptor subtypes for color vision in the Drosophila retina. The $435,052 award to the University of Massachusetts Boston aims to elucidate how conserved transcription factors and cis-regulatory elements specify blue- versus green-sensitive photoreceptor fates. Key research...
This Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) provides $469,854 in funding to Augusta University Research Institute, Inc. (doing business as Georgia Health Sciences) to investigate the role of histone deacetylases in retinal vascular senescence and diabetic retinopathy. The key research objectives are to: 1) Investigate the contribution of HDAC6 to retinal vascular senescence, diabetic microangiopathy, and diabetic retinopathy; and 2) Investigate the...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), provides $1,330,026 to The Trustees of the University of Pennsylvania to develop two novel mouse models of geographic atrophy, the advanced form of dry age-related macular degeneration (AMD). The goal is to evaluate the potential of a novel antioxidant, deuterated docosahexaenoic acid (D-DHA), to protect the retinal pigment epithelium and prevent or treat AMD progression. The research...
This Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) provides $531,670 to The Leland Stanford Junior University to assess the feasibility of a dietary intervention study for individuals with early-stage age-related macular degeneration (AMD). The key objectives are to: Demonstrate the feasibility of transitioning participants from a typical Western diet to a low-glycemic, Mediterranean diet. Evaluate the feasibility of obtaining sensitive retinal imaging and...

THE ROLE OF DIET AND AGING IN PHOTORECEPTOR HOMEOSTASIS AND VISUAL FUNCTION DECLINE - PROJECT SUMMARY/ABSTRACT MORE THAN HALF OF THE ELDERLY POPULATION SUFFER FROM AGE-RELATED EYE DISORDERS THAT COMPROMISE THEIR ABILITY TO PERFORM DAILY ACTIVITIES. AGING IS A SIGNIFICANT RISK FACTOR FOR SUCH DISORDERS, AND DIETARY RESTRICTION (DR) IS A ROBUST INTERVENTION THAT CAN SLOW AGING AND EXTEND HEALTHSPAN. NUTRIENT RESTRICTION INCREASES CIRCADIAN CLOCK AMPLITUDE, WHILE OVERNUTRITION AND OBESITY DAMPEN CIRCADIAN RHYTHMS, INCREASING THE RISK OF EYE DISEASES. HOWEVER, THE ROLE OF DR AND CIRCADIAN CLOCKS IN SLOWING AGE-RELATED DECLINE IN VISUAL FUNCTION IS NOT WELL UNDERSTOOD. THEREFORE, IT IS IMPERATIVE TO ADDRESS THIS GAP IN THE FIELD. THE GOAL OF THIS PROPOSAL IS TO DETERMINE THE MOLECULAR MECHANISMS THAT SLOW AGE-RELATED LOSS OF THE VISUAL SYSTEM, DEPENDING ON AGING AND DIET. WE HYPOTHESIZE THAT DR ENHANCES CIRCADIAN CLOCK GENE EXPRESSION, PROMOTING PHOTORECEPTOR HOMEOSTASIS, AND MODULATING LIFESPAN. OUR RECENT CIRCADIAN TRANSCRIPTOME PROFILING UPON DR SHOWED ENHANCEMENT OF GENES INVOLVED IN PHOTORECEPTOR HOMEOSTASIS AND DELAYED VISUAL SENESCENCE. PRIOR RESULTS SUGGEST THAT AGING LEADS TO A GRADUAL DECLINE IN CIRCADIAN RHYTHMS; HOWEVER, DR CAN SLOW THIS DECLINE. INHIBITION OF THE CIRCADIAN TRANSCRIPTION FACTOR, CLOCK (CLK), ACCELERATES THE AGE-RELATED DECLINE IN VISUAL FUNCTION, AND PHOTORECEPTOR DEGENERATION RESULTS IN SYSTEMIC INFLAMMATION AND SHORTENED LIFESPAN, WHICH DR PROTECTS AGAINST. WE HYPOTHESIZE THAT CLK PREVENTS LIGHT-INDUCED DAMAGE TO THE PHOTORECEPTORS, THUS SUPPORTING THE 'ESCAPE THE LIGHT HYPOTHESIS' FOR THE EVOLUTION OF CIRCADIAN CLOCKS. IN THIS STUDY, WE AIM TO DETERMINE THE CELLULAR PROCESSES IN PHOTORECEPTORS THAT PROTECT THEM FROM DAMAGE DUE TO AGE AND DIET, REVEALING NOVEL TARGETS FOR AGE-RELATED EYE DISEASES AND ASSOCIATED MORBIDITIES. WE PROPOSE THREE SPECIFIC AIMS TO ACHIEVE THIS GOAL. FIRST, WE WILL DETERMINE DOWNSTREAM EFFECTORS OF THE CORE CIRCADIAN CLOCK GENE, CLK, ALTERING THE AGE-RELATED DECLINE IN VISUAL SYSTEM FUNCTION UPON MODULATION OF DIET AND LIGHT. SECOND, WE WILL DETERMINE DIET-DEPENDENT TRANSCRIPTIONAL NETWORKS OF RHYTHMIC PHOTOTRANSDUCTION GENES AND THEIR IMPACT ON AGE-RELATED CHANGES IN VISUAL SYSTEM FUNCTION. THIRD, WE WILL STUDY FLY ORTHOLOGS OF GENES FROM OUR HUMAN GWAS STUDY THAT INFLUENCE RETINAL EYE AGING FOR THEIR INTERACTIONS WITH DIET, AGING, AND CIRCADIAN CLOCKS USING THE FLY. EXPECTED OUTCOMES OF THIS STUDY INCLUDE DELINEATING THE DIET AND AGING-DEPENDENT GENES INCLUDING CIRCADIAN TRANSCRIPTIONAL NETWORKS AND THEIR OUTPUTS INVOLVED IN PHOTOTRANSDUCTION HOMEOSTASIS TO MEDIATE CHANGES IN VISUAL SENESCENCE IN FLIES AND HUMANS. BY DETERMINING CELLULAR PROCESSES UNDER CIRCADIAN CONTROL IN THE PHOTORECEPTOR THAT PROTECT IT FROM DAMAGE DUE TO AGE, DIET, AND LIGHT, THIS STUDY WILL REVEAL NOVEL GENETIC TARGETS AND LIFESTYLE INTERVENTIONS MODULATING THE EFFECT OF DIET AND AGE ON EYE FUNCTION, PROVIDING POTENTIAL TREATMENT OPTIONS FOR AGE-RELATED EYE DISEASES AND ASSOCIATED MORBIDITIES.

Posted 6/26/24, 12:00 AM